Pharmazz, Inc. — SEC Form D Filing
Pharmazz, Inc. filed an SEC Form D on July 28, 2026, reporting $250K raised in Pharmaceuticals.
Form D filing details
- Filing
- SEC Form D
- Filing date
- July 28, 2026
- Amount reported
- $250K
- Round stage
- Seed
- Industry
- Pharmaceuticals
- Website
- https://pharmazz.com
What the company does
Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE
Problem
Pharmaceutical companies face challenges in developing and bringing new drugs to market efficiently and cost-effectively, often due to complex research, development, and regulatory hurdles.
Solution
Pharmazz, Inc. provides specialized contract research and development services, including preclinical testing, clinical trial management, and regulatory consulting, to accelerate drug discovery and approval for other pharmaceutical businesses.
Why now
The specific timing catalyst for Pharmazz is unclear from available information.
Source: SEC EDGAR Form D filing